| 期 |
栏目 |
标题 |
文件 |
| 卷 94, 编号 1 (2022) |
Original articles |
Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia |
(Rus)
|
| 卷 94, 编号 2 (2022) |
History of medicine |
The history of the discovery of the Helicobacter pylori |
(Rus)
|
| 卷 94, 编号 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
| 卷 94, 编号 2S (2022) |
Conference proceedings |
Assessment of exo- and endocrine function of pancreas following distal pancreatectomy |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Original articles |
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria |
(Rus)
|
| 卷 94, 编号 12 (2022) |
Original articles |
Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials |
(Rus)
|
| 卷 95, 编号 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
| 卷 95, 编号 2 (2023) |
Original articles |
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity |
(Rus)
|
| 卷 95, 编号 2 (2023) |
Original articles |
Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases |
(Rus)
|
| 卷 96, 编号 2 (2024) |
Original articles |
Efficacy of human placenta hydrolyzate in the treatment of patients with metabolic associated fatty liver disease at the stage of fibrosis (pilot study) |
(Rus)
|
| 卷 96, 编号 2 (2024) |
Original articles |
Nutritional status in advanced pancreatic cancer |
(Rus)
|
| 卷 96, 编号 2 (2024) |
Reviews |
Classification of chronic gastritis: historical digression and current state of the issue. A review |
(Rus)
|
